Importance of methicillin-resistant Staphylococcus aureus eradication in carriers to prevent postoperative methicillin-resistant Staphylococcus aureus surgical site infection
Related Experiment Video
Updated: Jun 3, 2026

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)
Published on: February 9, 2011
Walter E Pofahl1, Keith M Ramsey, Delores L Nobles
1Division of Clinical Effectiveness, Department of Surgery,The Brody School of Medicine at East Carolina University, Greenville, North Carolina, USA. pofahlw@ecu.edu
Abstract:
Although infrequent, postoperative methicillin-resistant Staphylococcus aureus (MRSA) surgical site infection (SSI) is associated with significant morbidity and cost. Previous studies have identified the importance of MRSA screening to diminish the risk of postoperative MRSA SSI. The current study quantifies the importance of eradication of the MRSA carrier state to prevent MRSA SSI. Beginning February 2007, all admissions to an 800-bed tertiary care hospital were screened for MRSA by nasal swab using rapid polymerase chain reaction-based testing. Patients found to be nasal carriers of MRSA were treated with 2 per cent mupirocin nasal ointment and 4 per cent chlorhexidine soap before surgery. The subset of patients undergoing procedures that are part of the Surgical Care Improvement Project (SCIP) were followed for MRSA SSI (n = 8980). The results of preoperative MRSA screening and eradication of the carrier state were analyzed. Since the initiation of universal MRSA screening, 11 patients undergoing SCIP procedures have developed MRSA SSI (0.12%). Of these, six patients (55%) had negative preoperative screens. Of the five patients with positive preoperative screens, only one received treatment to eradicate the carrier state. In patients who develop MRSA SSI, failure to treat the carrier state before surgery results in MRSA SSI.
Insights
Preventing methicillin-resistant Staphylococcus aureus (MRSA) surgical site infections (SSIs) requires eradicating MRSA nasal carriers before surgery. Treating carriers significantly reduces the risk of postoperative MRSA SSIs, improving patient outcomes.
Area of Science:
- Infectious Diseases
- Hospital Epidemiology
- Surgical Site Infections
Background:
- Postoperative methicillin-resistant Staphylococcus aureus (MRSA) surgical site infections (SSIs) cause significant morbidity and costs.
- Previous research highlighted MRSA screening's role in reducing SSI risk.
- This study quantifies the impact of eradicating MRSA nasal carriage.
Purpose of the Study:
- To determine the effectiveness of eradicating MRSA nasal carriage in preventing postoperative MRSA SSIs.
- To analyze the outcomes of universal MRSA screening and carrier state treatment.
Main Methods:
- Universal MRSA screening via nasal swab and rapid PCR testing for all hospital admissions since February 2007.
- Treatment of identified MRSA nasal carriers with mupirocin ointment and chlorhexidine soap prior to surgery.
- Follow-up of patients undergoing Surgical Care Improvement Project (SCIP) procedures for MRSA SSI development (n=8980).
Main Results:
- Eleven MRSA SSIs (0.12%) occurred among 8980 SCIP procedures.
- Six of the 11 patients (55%) had negative preoperative MRSA screens.
- Of five patients with positive screens, only one received carrier state eradication treatment.
Conclusions:
- Failure to treat MRSA nasal carriage before surgery is linked to MRSA SSI development.
- Preoperative MRSA screening and targeted carrier eradication are crucial for preventing SSIs.
- Effective MRSA carrier state management is essential in reducing postoperative infections.
Related Concept Videos
Clinical Significance of Antibiotic Resistance
Mechanism of Antibiotic Resistance in MRSA
Staphylococcal Skin Infections
Asepsis
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Hand hygiene
Hand washing...